Pneumococcal conjugate second or third-dose vaccines (PCVc) in Nauru
Nauru: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 66.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Nauru, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Nauru stood at 66.0%.
The figure is down 5.7% on the previous year.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Nauru peaked at 97.0% in 2022 and was at its lowest, 0.0%, in 2008.
That places Nauru 138th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Nauru, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 59.0% | — |
| 2022 | 97.0% | +64.4% |
| 2023 | 84.0% | -13.4% |
| 2024 | 70.0% | -16.7% |
| 2025 | 66.0% | -5.7% |
Nauru compared with similar countries
- Nauru's 66.0% is below the median for high income countries, which is 91.0%, 73% of the median. (63 countries reporting)
- Nauru's 66.0% is below the median for East Asia & Pacific, which is 81.0%, 81% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 62.7% | 0.0% | 97.0% | 6 |
Countries ranked near Nauru
More health data for Nauru
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8477 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,118 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2019)
- Population ages 00-04, female, annual growth rate -2.33 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0593 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.1333 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Nauru?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Nauru was 66.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Nauru?
- The highest recorded value was 97.0% in 2022.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Nauru?
- The lowest recorded value was 0.0% in 2008.
- How does Nauru rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Nauru ranks 138th out of 194 countries with data for 2025.
- Where does this Nauru data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).